https://www.lisavienna.at/news/detail/lisavienna-newsletter-april-edition-available/ 2018-04-27T09:48:26+02:00 0.5 https://www.lisavienna.at/news/detail/technoclone-30-years-coagulation-on-our-mind/ 2018-04-23T13:22:07+02:00 0.5 https://www.lisavienna.at/news/detail/curetis-subsidiary-ares-genetics-wins-incubator-stay-in-silicon-valley/ 2018-04-23T13:24:09+02:00 0.5 https://www.lisavienna.at/news/detail/boehringer-ingelheim-new-record-results-at-boehringer-ingelheim-regional-center-vienna/ 2018-05-16T23:40:37+02:00 0.5 https://www.lisavienna.at/news/detail/houskapreis-2018-oesterreichische-akademie-der-wissenschaften-und-swimsol-gewinnen-forschungspreis-d/ 2018-04-30T12:42:20+02:00 0.5 https://www.lisavienna.at/news/detail/imba-ameres-and-his-team-win-the-houska-award-for-slamseq/ 2018-05-01T10:50:34+02:00 0.5 https://www.lisavienna.at/news/detail/glaxosmithkline-launcht-aufklaerungsinitiative-mums-vs-meningitis-mit-anne-geddes/ 2018-05-01T11:18:04+02:00 0.5 https://www.lisavienna.at/news/detail/oesterreichischer-verband-der-impfstoffhersteller-weltimpfwoche-impferfolge-und-verbesserungspotenz/ 2018-05-01T12:57:07+02:00 0.5 https://www.lisavienna.at/news/detail/boehringer-ingelheim-mit-sehr-erfolgreichem-geschaeftsjahr-2017/ 2018-05-01T13:08:56+02:00 0.5 https://www.lisavienna.at/news/detail/sanochemia-pharmazeutika-ag-bescheid-des-basg-zum-eingeschraenkten-gmp-zertifikat-liegt-vor/ 2018-05-01T14:34:16+02:00 0.5 https://www.lisavienna.at/news/detail/pfizer-welt-meningitis-tag-wir-teilen-alles-manchmal-auch-unbewusst/ 2018-05-03T11:56:09+02:00 0.5 https://www.lisavienna.at/news/detail/gsk-am-24-april-ist-welt-meningitis-tag/ 2018-05-03T12:15:55+02:00 0.5 https://www.lisavienna.at/news/detail/iqvia-apotheken-versandhandel-waechst-kontinuierlich/ 2018-05-03T12:31:55+02:00 0.5 https://www.lisavienna.at/news/detail/gsk-am-105-ist-welt-lupus-tag/ 2018-05-06T11:02:55+02:00 0.5 https://www.lisavienna.at/news/detail/piur-imaging-high-end-low-cost-sensor-based-tomographic-ultrasound-imaging/ 2018-05-16T23:43:40+02:00 0.5 https://www.lisavienna.at/news/detail/pfizer-gezielt-gegen-blutkrebs-neue-therapie-gegen-akute-myeloische-leukaemie-aml/ 2018-05-06T10:57:18+02:00 0.5 https://www.lisavienna.at/news/detail/janssen-cilag-guidebook-hilft-blutkrebspatienten-bei-fragen-zu-ihrer-krankheit/ 2018-05-07T07:47:39+02:00 0.5 https://www.lisavienna.at/news/detail/vamed-from-polyclinics-to-university-hospitals-vamed-continues-to-expand-its-international-presen/ 2018-05-23T07:52:44+02:00 0.5 https://www.lisavienna.at/news/detail/sanochemia-financing-for-clinical-development-of-tolperisone-usa-successfully-completed-start-of/ 2018-05-17T00:46:26+02:00 0.5 https://www.lisavienna.at/news/detail/sanochemia-pharmazeutika-ag-eingeschraenktes-gmp-zertifikat-der-sanochemia-pharmazeutika-ag/ 2018-05-07T13:37:14+02:00 0.5 https://www.lisavienna.at/news/detail/iqvia-erstattungsmarkt-2018-erwartetes-wachstum-knapp-unter/ 2018-05-07T13:42:41+02:00 0.5 https://www.lisavienna.at/news/detail/macroarray-diagnostics-erhaelt-eur-25-mio-eu-foerderung-fuer-eine-allergiediagnostik-innovation/ 2018-05-07T13:55:50+02:00 0.5 https://www.lisavienna.at/news/detail/advanced-training-good-manufacturing-laboratory-clinical-practice/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/lisa-vr-news-022006-published/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/relaunch-lisa-vr-web/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/premiere-austrian-life-sciences-directory-presented-at-bio-europe/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/kick-off-7th-eu-research-framework-programme/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/award-ceremony-austrian-life-sciences-award-alsa/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/oegbt-conference-future-development-of-new-biological-entities/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/novartis-campus-party-2006/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/lisa-vr-at-bio-2007/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/new-lisa-vr-executive-board-member/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/lisa-vr-news-012007-published/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/new-lisa-vr-brochure-available/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/lisa-vr-at-vienna-vaccines-conference-infectious-diseases-booklet/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/conference-challenges-for-vaccine-development-medical-needs-and-social-implications/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/lisa-vr-annual-report-2006-online/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/austrianova-completes-first-closing-of-35-m-euro-series-b-financing/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/campus-party-2007-at-university-of-veterinary-medicine-vienna/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/success-stories-at-vuw-campus/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/city-of-vienna-eur-10-millions-for-biotech-equipment/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/ground-breaking-ceremony-at-muthgasse-additional-30000-m2-lab-space-until-102009/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/eucodis-gmbh-signs-with-sandoz-gmbh-a-collaboration-agreement/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/intercell-and-novartis-form-world-leading-strategic-partnership-to-drive-vaccines-innovation/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/febs-congress-molecular-machines/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/first-child-vaccinated-with-intercell-je-vaccine-in-india-pediatric-phase-ii-trial-started/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/affiris-begins-clinical-testing-of-alzheimers-vaccine/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/ad-hoc-announcement-according-to-15-wphg-sanochemia-pharmazeutika-ag-wkn919963/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/intercell-announces-q2-2007-results/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/nabriva-initiation-of-clinical-phase-i-study-of-topical-antibiotic/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/sanochemia-files-scanlux-in-us/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/intercells-therapeutic-hcv-vaccine-meets-primary-endpoints-in-phase-ii-interim-analysis/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/sanochemia-partner-avigen-inc-reports-successful-completion-of-two-key-clinical-trials-in-the-deve/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/sanochemia-nine-months-report-2007-published/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/bc-privatstiftung-forschungspreis-einreichungen-zum-houskapreis-2018-ab-sofort-moeglich/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/sanochemia-us-partner-avigen-commences-multicentric-phase-ii-study-in-the-development-programme-for/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/boehringer-ingelheim-to-initiate-first-phase-iii-pivotal-study-for-new-oncology-compound-bibw-2982/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/ablynx-and-boehringer-ingelheim-announce-major-global-strategic-alliance-to-discover-develop-and-co/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/antibody-engineering-company-f-star-raises-eur-6-million-in-series-a-financing-round/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/intercell-announcement-of-novartis-share-in-voting-rights/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/austrianova-establishes-singapore-subsidiary/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/improved-business-in-life-sciences-lecture-program-starts-2007/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/umbrella-brand-life-science-austria-launched/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/kirsten-peter-rabitsch-award-2007/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/thomas-jenuwein-receives-the-erwin-schroedinger-prize-of-the-austrian-academy-of-sciences/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/lisa-vr-at-biotechnica-2007/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/lisa-vr-lecture-at-open-days-2007-in-brussels/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/lisa-vr-sponsors-best-of-biotech-2007/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/international-phd-program-in-molecular-life-sciences-deadline-for-applications-november-25-2007/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/sanochemia-tolperisone-viveo-r-launched/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/lisa-vr-news-022007-published/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/onepharm-signs-cooperation-agreement-with-minophagan-japan/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/sanochemia-consolidation-of-alcasynn-holding-in-20062007-financial-year/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/otto-bock-showcases-europes-first-neurally-controlled-prosthesis/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/lisa-vr-sponsors-bio-europe-2007/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/viennese-businesses-at-bio-europe-2007-hamburg-12-14-november/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/vienna-biocenter-phd-symposium-2007-from-molecules-to-mind/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/lisa-vr-goes-medica-2007/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/intercell-all-development-programs-on-track/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/affiris-granted-european-patent-for-alzheimers-vaccine/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/wwtf-four-new-science-chairs-for-vienna/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/intercell-novartis-alliance-next-eur-80-million-payment-received/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/spotlight-on-life-sciences-funding-in-vienna/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/antibody-engineering-company-f-star-raises-eur-3-million-in-a-second-closing-of-its-series-a-financi/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/fibrex-medical-completes-enrolment-of-phase-ii-trial-of-treatment-for-reperfusion-injury-in-myocardi/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/intercells-clinical-data-on-japanese-encephalitis-vaccine-published-in-the-lancet/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/statens-serum-institut-ssi-intercell-icll-and-aeras-global-tuberculosis-vaccine-foundation-ae/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/fwf-visiting-scientists-programme-translational-brainpower-deadline-for-applications-27-3-2008/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/fwf-new-call-for-translational-research-projects-deadline-27-3-2008/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/martin-nowak-five-rules-for-cooperation/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/intercell-submits-marketing-authorization-application-maa-to-emea-for-licensure-of-japanese-enceph/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/for-the-fruit-fly-everything-changes-after-sex-imp-researchers-find-molecular-switch-for-behavior/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/wwtf-6-life-sciences-projects-funded-with-eur-43-million-in-total/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/antibody-engineering-company-f-star-appoints-three-pioneers-in-antibody-engineering-and-development/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/gsk-and-european-foundation-for-the-study-of-diabetes-efsd-commit-eur-1-million-to-diabetes-resear/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/intercell-receives-milestone-payment-from-merck-co-inc-triggered-by-initiation-of-phase-ii-clini/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/outstanding-result-for-affiris-alzheimers-vaccine-in-the-latest-thomson-the-ones-to-watch-ranking/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/intercell-finalizes-submission-of-us-biological-license-application-bla-to-fda-for-licensure-of-ja/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/sanochemia-preliminary-figures-for-the-20062007-fiscal-year-1-10-2006-30-9-2007/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/phadia-invests-in-vbc-genomics/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/successful-collaboration-between-us-army-and-intercell-towards-a-novel-vaccine-against-japanese-en/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/2-erc-grants-for-imp-and-imba-researchers/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/marinomed-signs-collaboration-with-boehringer-ingelheim-for-anti-viral-nasal-spray-against-common-co/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/intercells-results-on-a-novel-pneumococcal-protein-based-vaccine-published-in-the-journal-of-experi/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/60th-anniversary-of-boehringer-ingelheim-in-austria/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/intercell-icll-and-the-path-malaria-vaccine-initiative-announce-new-collaboration-for-a-vaccine-ag/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/intercell-receives-manufacturers-licence-for-future-commercial-manufacturing-of-its-vaccine-against/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/aas-novartis-research-prize-for-karel-riha/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/sanochemia-final-results-for-20062007-fiscal-year/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/imp-molecular-glue-with-new-effect/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/agnes-streissler-as-new-representative-of-zit-in-lisa-vrs-advisory-board/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/intercells-therapeutic-hepatitis-c-vaccine-meets-primary-endpoints-in-phase-ii/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/vaccine-formulated-with-intercells-adjuvant-ic31-part-of-a-broader-collaboration-to-fight-tuberculo/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/medical-university-of-vienna-and-emergentec-ovarian-cancer-systems-biology-goes-clinic/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/dance-competition-dance-your-phd-at-imp/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/che-ranking-university-of-viennas-biology-member-of-the-excellence-group/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/vienna-biotech-company-tissuegnostics-expands-its-business-by-now-in-japan-and-usa/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/sanochemia-first-quarter-report-20072008/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/intercell-completes-phase-i-clinical-trial-for-an-improved-seasonal-influenza-vaccine-formulated-wit/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/marinomed-biotechnologie-gmbh-presents-its-first-product-carrageloser-in-the-nasal-spray-coldama/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/affiris-expands-patent-portfolio-for-alzheimers-therapies/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/sanochemia-withdrawal-from-planned-investment-in-countervail/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/intercell-licensure-application-for-japanese-encephalitis-vaccine-submitted-to-therapeutic-goods-ad/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/intercell-announces-q4-and-preliminary-full-year-2007-results/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/boku-new-christian-doppler-pilot-lab-for-rapid-test-systems-for-allergenic-food-contaminants/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/ccri-coordinates-new-fp7-funded-project-direct/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/winning-projects-in-the-best-of-biotech-competition-announced/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/antibody-engineering-company-f-star-opens-second-research-site-in-cambridge-uk/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/new-lisa-vr-event-calender/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/fully-implantable-hearing-device-debuts-at-the-general-hospital-vienna-akh/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/vogelbusch-makes-bioethanol-more-efficient/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/cell-publication-for-the-french-connection-prohaska-lab-and-taylor-group-a-function-for-stomatin/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/antibody-engineering-company-f-star-buys-back-royalty-obligations-tvm-capital-joins-investor-syndic/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/mfpl-and-akh-united-publication-in-the-american-journal-of-obstetrics-and-gynecology/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/claus-hofer-new-representative-of-zit-in-lisa-vrs-advisory-board/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/updated-booklet-on-antiinfectives-vaccines-infectious-diseases-available/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/kwizda-joint-development-of-biosimilar-product-with-the-indian-manufacturer-intas-biopharmaceutical/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/sfb-grant-awarded-to-mfpl-and-imp-consortium-chromosome-dynamics-unravelling-the-function-of-chrom/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/vela-laboratories-receives-the-gmp-certificate-for-its-analytical-and-quality-control-laboratories/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/new-laboratory-building-for-akh-and-muw-to-celebrate-topping-out-ceremony/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/boehringer-ingelheim-strong-growth-in-central-and-eastern-europe/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/new-international-field-of-research-established-allergooncology/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/intercells-investigational-vaccine-against-japanese-encephalitis-shows-excellent-safety-immunogen/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/new-strategies-against-bird-flu/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/innovative-high-potential-promotion-at-the-max-f-perutz-laboratories-3-international-junior-group/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/strong-alliance-to-fight-fungal-infections/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/intercell-receives-the-vaccine-industry-excellence-award/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/lisa-vr-publishes-flyer/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/baxter-global-player-strengthens-austrian-operations-future-research-prospects/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/biosimilar-g-csf-cooperation-on-three-continents/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/intercell-ag-to-acquire-iomai-corporation-to-expand-late-stage-product-pipeline-strengthen-leaders/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/lisa-vr-news-012008-published/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/onepharm-acquires-bionetwork-patents-and-confirms-it-halts-bone-loss-in-periodontitis/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/andrea-barta-elected-as-full-member-of-the-austrian-academy-of-sciences/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/salad-salmonella-food-poisoning-as-a-side-dish/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/giulio-superti-furga-elected-for-membership-to-the-german-academy-of-sciences-leopoldina/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/lisa-vr-annual-report-2007-available/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/new-mechanisms-of-stem-cell-regulation/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/intercell-granted-early-termination-of-hsr-waiting-period-for-iomai-acquisition/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/the-max-f-perutz-laboratories-invite-you-to-celebrate/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/iomai-announces-publication-in-the-lancet-of-phase-ii-study-demonstrating-significant-efficacy-of-tr/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/intercell-receives-milestone-payment-triggered-by-initiation-of-further-clinical-trial-for-flu-vacci/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/start-of-phase-i-study-for-pandemic-influenza-vaccine/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/intercell-licensure-application-for-japanese-encephalitis-vaccine-submitted-to-canadian-division-o/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/sanochemia-us-patent-granted-for-the-formulation-and-use-of-the-active-pharmaceutical-ingredient-pv/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/earlybird-venture-capital-leads-investiment-in-miracor/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/best-of-biotech-business-plan-the-winners/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/the-centre-of-innovation-technology-of-the-city-of-vienna-supports-7-tesla-project-at-muvgeneral/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/nabriva-therapeutics-announces-appointment-of-new-ceo/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/start-of-phase-i-study-for-intranasal-pandemic-influenza-vaccine-deltaflu/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/iomai-acquisition-granted-clearance-by-us-authorities/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/affiris-milestone-reached-in-clinical-trial-of-alzheimers-vaccine/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/infection-of-streptococcus-unkown-receptor-molecule-responsible-for-immune-response/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/promising-new-approach-to-cancer-therapy/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/alexander-von-gabain-member-of-eit-governing-board/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/iomai-shareholders-approve-acquisition-by-intercell/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/affiris-and-onepharm-listed-as-promising-european-biotech-companies/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/intercell-ag-closes-acquisition-of-iomai-corporation/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/sumo-publication-of-the-pichler-group-in-molecular-cell/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/intercell-ag-announces-q2h1-2008-results-gives-update-on-business/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/extreme-competitive-sports-a-fitness-test-for-dna/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/us-defense-logistics-agency-announces-plans-to-enter-into-supply-contract-to-purchase-japanese-encep/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/sanochemia-nine-months-report-20072008/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/intercell-announces-initiation-of-further-phase-ii-clinical-trial-of-v710-an-investigational-vaccine/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/redl-life-science-patent-attorneys-open-office-at-tech-gate-tower/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/fibrex-medical-effectiveness-of-fx06-in-preventing-cardiac-damage/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/favourable-six-months-follow-up-results-from-intercells-phase-ii-therapeutic-hepatitis-c-program/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/additional-boost-to-vienna-as-biotech-location/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/sanochemia-first-patent-granted-in-austria-on-the-improved-synthsis-process-for-the-manufacture-of/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/new-christian-doppler-laboratory-at-boku-vienna/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/switch-off-light-on-molecular-biologist-discovers-new-control-mechanism-in-cell-signalling/ 2019-03-19T20:24:33+01:00 0.5 https://www.lisavienna.at/news/detail/apeptico-completes-eur3-million-financing-round/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/themis-bioscience-and-institut-pasteur-form-rd-alliance/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/themis-bioscience-completes-series-a-financing-round-eur-5-million-to-advance-promising-vaccine-ca/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/best-of-biotech-2010-the-winners/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/best-of-biotech-2010-the-winners/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/apeiron-acquires-rights-for-phase-iii-immunotherapy-against-high-risk-neuroblastoma-from-ccri-and-si/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/f-star-and-merck-serono-to-collaborate-in-the-discovery-and-development-of-novel-targeted-biologics/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/avir-green-hills-reaches-important-milestone/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/international-contacts-boost-business/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/two-pi-awarded-first-prize-for-innovations-in-user-centered-hearing-aid-fitting/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/roche-enters-into-a-strategic-alliance-with-technoclone/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/business-treff-at-ame-international/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/business-treff-at-ame-international/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/cemm-vetmeduni-jak-of-all-trades-not-of-leukaemia-therapy/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/intercell-positive-results-from-two-phase-iii-studies-supporting-pediatric-label-extension-of-je-va/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/fwf-ovarian-cancer-new-tumour-suppressor-gene-identified/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/imba-josef-penninger-announced-aaas-fellow/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/business-seminar-medtech-changeover-en-60601/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/eucodis-business-and-sales-activities-in-usa-launched/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/business-seminar-medtech-changeover-en-60601/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/apeiron-initiates-clinical-study-to-investigate-prevention-of-radiationinduced-skin-damage-in-cancer/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/miracor-receives-35-million-cash-infusion-to-begin-pivotal-clinical-ramses-trial-of-its-picso-sy/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/austromed-spricht-sich-mit-vehemenz-fuer-eu-richtlinie-zu-nadelstichverletzungen-aus/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/intercell-starts-the-second-part-of-a-phase-i-clinical-trial-with-vaccine-candidate-to-prevent-clost/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/imba-micrornas-fight-high-cholesterol/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/activartis-substantial-amendment-to-trial/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/rueckblick-bio-europe-spring-2012/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/acib-gewinnt-2-preis-beim-science2business-award-2012/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/marinomeds-iota-carrageenan-nasal-spray-achieves-positive-clinical-results-against-common-cold/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/imba-the-scientist-votes-imba-second-to-top-international-workplace/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/gesundheits-unternehmen-baxter-mit-guetesiegel-betriebliche-gesundheitsfoerderung-ausgezeichnet/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/astrid-released-its-free-comprehensive-biobank-guideline/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/astrid-released-its-free-comprehensive-biobank-guideline/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/imp-magnetic-navigation-putting-the-cat-among-the-pigeons/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/miracor-medical-is-a-finalist-for-the-2012-red-herring-top-100-europe-award/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/mehr-manpower-fuer-austromed/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/lisavienna-business-seminar-china/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/apeptico-at-the-long-night-of-research/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/imp-ec-commissioner-geoghegan-quinn-visited-the-campus-vbc/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/imba-parkinsons-disease-causal-research-leads-to-new-therapies/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/6th-cemm-karl-landsteiner-lecture/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/imp-of-yeast-and-men-an-evolutionary-tale/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/intercell-annonces-eur-250-million-financing-from-bb-biotech-and-proposed-private-placement/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/intercell-ag-announces-q1-2012-results-and-operational-update/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/wwtf-life-sciences-call-2012/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-wien-cd-laboratory-hi-tech-prostheses-personalised-movement-pattern-recognition-helps-with/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/intercell-completes-equity-private-placement-of-eur-152-million-at-a-price-of-eur-230-per-new-shar/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/f-star-real-change-after-change-of-scene/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/cemm-austrodrugs/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/apeptico-completes-a-eur-34-million-financing-round/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/imp-jan-michael-peters-elected-corresponding-member-of-the-austrian-academy-of-sciences/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/zytoprotec-completes-phase-iii-trial-of-novel-dialysate/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/1-viirus-symposium-am-wiener-cemm/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/rueckblick-zukunftsreise-nach-china-pharma-und-biotechnologie/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/rueckblick-zukunftsreise-nach-china-pharma-und-biotechnologie/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/imba-self-learning-computer-program-analyzes-cell-division-process/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/miracor-granted-several-us-patents-for-its-picsor-system-to-treat/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/baxter-builds-eur-30-million-production-facility-in-vienna/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/bob-phase-1-best-business-ideas/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/bob-phase-best-business-ideas/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/forest-laboratories-and-nabriva-therapeutics-sign-agreement/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/vienna-life-sciences-explore-china/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/savira-signs-collaboration-and-license-agreement-with-roche/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/savira-signs-collaboration-and-license-agreement-with-roche/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/affiris-parkinsons-vaccine-worldwide-first-clinical-study-in-vienna/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/business-treff-at-ait/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/business-treff-at-ait/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/business-treff-at-ait/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/cemm-principal-investigator-kaan-boztug-awarded-start-prize/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/imp-the-art-of-cell-division/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/austromed-sieht-gesundheitsversorgung-gefaehrdet/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/gmi-new-efficient-method-for-gwas-analysis/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/rueckblick-bio-international-convention-2012/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/campus-vienna-biocenter-new-play-by-carl-djerassi-at-the-campus-vienna-biocenter-vienna/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/aws-bob-phase/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/boehringer-ingelheim-bioxcellence-distinctive-brand-for-the-biopharmaceutical-contract-manufacturin/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/biomay-to-present-at-the-rodman-renshaw-14th-annual-global-healthcare-conference/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/biomay-innovative-grass-pollen-allergy-vaccine-shows-efficacy-in-phase-iia-trial/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/apeptico-initiates-phase-ii-trial-with-ap301-in-patients-with-pulmonary-oedema/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/tu-wien-zell-stress-erhoeht-die-produktivitaet/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/miracor-reports-first-in-man-results-using-its-picsor-system-to-treat-severe-heart-attack-patients/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-vienna-a-weak-heart-produces-a-poor-appetite/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-vienna-announces-collaboration-with-the-johns-hopkins-university-carey-business-school/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/cemm-research-work-published-in-nature/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/nabriva-therapeutics-announces-management-changes/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-vienna-parkinsons-newly-discovered-antibody-could-facilitate-early-diagnosis/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/imba-how-malnutrition-leads-to-inflamed-intestines/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/zit-call-smart-vienna-2012/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/uni-vienna-ion-selectivity-in-neuronal-signaling-channels-evolved-twice-in-animals/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-vienna-molecular-causes-for-life-threatening-fungal-infections-in-case-of-sepsis-unravelled/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/bmwfj-mitterlehner-fe-programme-des-wirtschaftsministeriums-als-europaweite-vorzeigemodelle-hervo/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/medmedia-oesterreichisches-kompetenzzentrum-fuer-medizin-apps/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/oeaw-cemm-one-of-the-best-places-to-work-in-academia/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/vetmeduni-wien-praezisere-suche-im-dschungel-der-krebsentstehungs-gene/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/baxter-mitarbeiter-und-umwelt-profitieren-vom-neuen-gruenen-gebaeude-in-wien/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/biotechnologie-dritter-bericht-des-biopatent-monitoring-komitees-liegt-vor/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-wien-neue-erkenntnisse-bei-hautkrebs-protein-hemmt-bildung-von/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-wien-massenspektrometrie-neue-technik-eroeffnet-verbesserte-diagnose-optionen/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-wien-nervenzell-typen-im-gehirn-charakterisiert/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-wien-hepatitis-c-fruehere-therapie-vertraeglicher-und-effektiver/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/biofrontera-ag-vertriebsvereinbarung-mit-der-pelpharma-handels-gmbh-fuer-ameluzr-in-oesterreich/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/tu-austria-unter-neuer-fuehrung/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/wirtschaftsagentur-sachgueteraktion-2012/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/boehringer-ingelheim-waechst-im-1-halbjahr-2012-erneut-schwieriges-geschaeftsumfeld-fuer-die-2-jahr/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/ge-healthcare-konzern-von-weltruf-in-oesterreich-medizintechnik-auf-olympischem-niveau/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/ffg-eine-million-euro-fuer-junge-innovative-unternehmen/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/imp-fliegen-sex-wann-lohnt-sich-ein-flirt/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/aws-3-call-der-venture-capital-initiative/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/pharmig-neues-forschungsnetzwerk-fuer-kinderarzneimittel/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/gmi-vom-unkraut-zum-menschen/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/pfizer-oesterreich-veroeffentlicht-seinen-zweiten-nachhaltigkeitsbericht/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/pharmig-generika-kein-allheilmittel-zur-budgetsanierung/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-vienna-cardiac-arrest-quicker-emergency-assistance-would-save-many-lives/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-vienna-treatment-of-heart-attacks-with-aposec-further-mechanism-unravelled/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/uni-wien-neuer-wirkstoff-im-kampf-gegen-krebs/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/apeptico-presents-clinical-results-of-its-inhalation-therapy-for-prevention-of-oedematous-respirator/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/biolitec-ag-resolution-regarding-merger-passed-by-majority-at-the-extraordinary-general-meeting/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/neu-marx-wuestenrot-kauft-labor-und-buerohaus-marxbox/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-vienna-emergency-medicine-heart-lung-machine-brings-clinically-dead-patients-back-to-life/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/review-lisavienna-hosts-uk-delegation-regenerative-medicine/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/sanochemia-export-radiologie-erhoehte-nachfrage-aus-aegypten/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/review-lisavienna-hosts-uk-delegation-regenerative-medicine/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/josef-proell-folgt-christian-konrad-als-praesident-der-lbg/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/imba-internationales-wissenschaftliches-symposium-zum-thema-seltene-genetische-erkrankungen/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/kav-haeupl-wehsely-und-marhold-legen-grundstein-fuer-krankenhaus-nord/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-wien-hoffnung-fuer-ueber-und-untergewichtige-hormon-zuegelt-und-steigert-den-appetit/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/arsanis-expands-its-anti-infective-monoclonal-antibody-programs-with-additional-grant-support/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/imp-the-biology-of-emotions/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/affiris-fempower-fuer-molekulare-grundlagen-zukuenftiger-impfstoffe/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/celebrating-ten-years-of-lisavienna-the-vienna-life-science-cluster/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/intercells-partner-biological-e-ltd-launches-japanese-encephalitis-vaccine-jeevr-in-india/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/gmi-pflanzenforschung-genomstabilitaet-in-ei-und-spermazellen/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/pharmig-medizinischer-fortschritt-braucht-forschung/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/forschungsrat-fordert-dringend-eine-erhoehung-der-oeffentlichen-fe-ausgaben/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/hookipa-is-awarded-a-grant-from-the-austrian-research-promotion-agency/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/intercell-announces-phase-i-results-on-its-vaccine-enhancement-patch-vep-with-pandemic-influenza-a/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/mediatum-top-management-studie-2012/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/sanochemia-synthetisches-galantamin-fuer-den-weltmarkt/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/pharmig-begruesst-straftatbestand-fuer-arzneimittelfaelschungen/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/lisavienna-business-seminar/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-wien-alzheimer-ausbruch-der-krankheit-kann-praeventiv-verzoegert-werden/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/rfre-europ-strukturfonds-als-massgebliches-finanzierungsinstrument-fuer-die-forschung-attraktiver-ge/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/diagnosia-professionelle-arzneimittelinformationen-fuer-unterwegs/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/gsk-verantwortung-gegenueber-unserer-umwelt/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-wien-bei-alzheimer-sind-auch-fremde-proteine-im-spiel/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/eucodis-quality-management-system-iso90012008-certificate-received/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-wien-lebenswandel-beeinflusst-das-krebsrisiko-positiv-wie-negativ/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/pharmig-tierversuche-forschung-nicht-durch-buerokratische-huerden-gefaehrden/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/cvbc-tierversuchsgesetz-oesterreichische-forscher-fuerchten-einschraenkungen-fuer-die-krebsforschung/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/wirtschaftsagentur-wien-erste-foerder-app-fuer-wiener-unternehmen/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-wien-brain-tumours-artificial-stimulation-of-the-immune-system-could-mean-less-aggressive-t/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/world-medtech-forum-lucerne/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/oesterreichische-gesellschaft-fuer-senologie-mein-krebs-ist-nicht-dein-krebs/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/pfizer-austria-optimiert-seine-unternehmenswebseite-fuer-mobile-endgeraete/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/ait-den-gehirnstroemen-auf-der-spur/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/profem-gewinnt-fempower-call/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/wechsel-in-der-globalen-unternehmensleitung-von-boehringer-ingelheim/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-wien-esmo-kongress-cholesterinsenker-gegen-krebs/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/cemm-research-work-published-in-nature-chemical-biology/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/cemm-winter-et-al-understanding-off-target-synergy-for-kinase-inhibitors-against-drug-resistant-c/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/cemm-research-work-published-in-nature-chemical-biology/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/bio-europe-2012/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/medica-2012/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-wien-geriatric-medicine-far-more-than-mere-elderly-care-medicine/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/oeaw-kritik-an-entwurf-fuer-neues-tierversuchsgesetz/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/mediatum-human-excellence-in-life-science-verstaerkt-team/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-wien-newly-developed-simple-test-for-gestational-diabetes/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/sanochemia-und-katama-unterzeichnen-exklusiven-lizenzvertrag-fuer-tolpersion-in-nordamerika/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/oesterreichische-aerztekammer-schlaganfall-warnsignale-nicht-verharmlosen/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/acib-im-rampenlicht-der-internationalen-biotechnologie/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/bmfwf-karlheinz-toechterle-fwf-und-ffg-sind-massgebliche-stuetzen-des-heimischen-forschungsstandortes/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/my-sugr-health-challenges-von-sanofi-fuer-typ-1-diabetiker-start-der-kooperation-mit-app-entwickle/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/lebenshilfe-empfiehlt-nationalen-strategieplan-zu-demenz/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/newsletter-022011/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/fwf-klif-bringt-17-weitere-projekte-fuer-die-klinische-forschung-in-oesterreich/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/alsa-2012-rekordanzahl-an-bewerbungen/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/imba-wien-im-zentrum-seltener-genetischer-erkrankungen/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-wien-12-aus-17-meduni-wien-raeumt-bei-projektfoerderungen-fuer-die-klinische-forschung-ab/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/aws-aviso-best-of-biotech-2012/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-wien-lymphoma-cancer-women-respond-better-to-treatment-with-antibodies-than-men/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/inits-dr-irene-fialka-ist-neue-geschaeftsfuehrerin-der-inits-universitaeres-gruenderservice-wien-gmbh/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-wien-fuer-jeden-rheuma-patienten-eine-ganz-persoenliche-therapie/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-vienna-new-treatment-option-for-cancer-diabetes-and-obesity/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-vienna-success-in-the-treatment-of-aggressive-lymphatic-cancer/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/pfizer-wenn-das-leben-angst-macht/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/schicksal-amputation-gefaessbedingte-offene-wunden-koennen-heilen/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/imp-die-hohe-kunst-des-schubladendenkens/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/acr-kooperationspreis-2012/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/modernste-intensivbettenstation-oesterreichs-im-auva-unfallkrankenhaus-meidling-eroeffnet/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-wien-apfelallergie-symptome-koennten-kuenftig-deutlich-vermindert-werden/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/imp-der-stoff-aus-dem-das-gedaechtnis-ist/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/fopi-european-health-literacy-project-gewinnt-european-health-award-2012/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/lbi-research-in-animal-model-identifies-new-lymphoma-treatment/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/bob-minister-for-economic-affairs-mitterlehner-honours-the-best-business-ideas-of-life-science/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-vienna-positron-emission-tomography-makes-effect-of-antidepressants-measurable/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/vetmeduni-wien-wie-evolutionaere-anpassung-in-den-genen-entsteht/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/best-of-biotech-confers-the-medtech-award-das-goldene-wiener-herz-for-a-second-time/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/preisregen-fuer-acib-forscherinnen/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/imba-breast-cancer-advance-wins-imba-74m-us-award/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/rcc-announces-marketing-partnership-with-virusure-for-india/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/lisavienna-business-treff/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/proell-lbg-ist-starker-partner-fuer-die-forschung/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/uni-wien-computer-erlaubt-neue-einblicke-in-ablaeufe-in-zellen/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/kh-barmherzige-schwestern-kleinste-tumoren-gut-entdeckt-sicher-entfernt/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/andreas-hauer-joining-savira-pharmaceuticals-as-cfo/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/neuer-pressekontakt-bei-pfizer-oesterreich/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/bmwfj-mitterlehner-starke-foerderimpulse-fuer-forschungsintensive-klein-und-mittelbetriebe/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/akh-wien-erstes-auditorisches-hirnstamm-implantat-in-oesterreich/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/gsk-setzt-sich-ein-fuer-frauen-in-fuehrung/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/haplogen-haploid-halbe-zellen-mit-doppeltem-nutzen/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/uni-wien-hautheilung-ganz-natuerlich-und-nano/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/tu-wien-das-elektronenmikroskop-mit-dem-extra-dreh/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-viennalook-under-the-skin-facilitates-faster-diagnosis-and-treatment-of-skin-cancer/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/mit-ait-technologie-lichtteilchen-zaehlen/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/pharma-app-darm-aktiv-hilft-colitis-ulcerosa-und/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/ofi-gewinnt-den-acr-kooperationspreis-2012/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-vienna-dermatitis-could-be-suppressed-as-it-develops/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/alsa-2012-wissenschaftspreis-in-wien-vergeben/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/spitzenforschung-ait-erhaelt-k-projekt/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/intercell-ag-announced-its-financial-results-for-q3-2012/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/pfizer-gesundes-altern-kann-kosten-verringern/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/stadt-wien-investiert-10-millionen-in-biotech-schwerpunkt-der-boku-innovationsimpuls-fuer-die-ganze/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/gsk-siegel-open-company-und-best-recruiter/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/wwtf-zeichnet-fuenf-meduni-wien-projekte-aus/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-wien-europareife-fuer-individuelles-therapie-modell-bei-diabetes-und-uebergewicht/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/fopi-tritt-als-erster-unternehmensverband-dem-un-global-compact-bei/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/lisa-praesentiert-oesterreichische-biotech-innovationskraft-auf-europas-groesster-partnering-messe/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-vienna-epilepsy-in-children-surgery-can-eliminate-the-need-for-medication/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/haplogen-partners-with-evotec-to-develop-drugs-for-infectious-diseases/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/pfizer-lungenkrebsmonat-november/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/pharmig-praesident-rumler-gesundheitsziele-im-bereich-infektionskrankheiten/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/neuer-aws-leitfaden-zur-durchsetzung-von-schutzrechten/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/aws-praesentiert-oesterreichische-medizintechnik-highlights-auf-weltweit-groesster-medizintechnik-messe/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-wien-epilepsy-in-children-surgery-can-eliminate-the-need-for-medication/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/marinomed-granted-chinese-patent-for-antiviral-polymer/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/pfizer-gemeinsam-rauchfrei/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-wien-kombi-geraet-fuer-mr-und-pet-fuer-wiener-akh/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/sekisui-medical-japan-and-virusure-agree-marketing-cooperation-for-japan/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/bmwf-karlheinz-toechterle-eu-forschungsfoerderung-wirkt/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/austromed-herbstveranstaltung/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/ihe-day-2012-im-zeichen-neuer-elga-projekte/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/sanochemia-notice-of-allowance-fuer-tolperison-herstellverfahren-fuer-den-us-markt/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/ait-innovation-verbessert-diagnose-und-therapie-fuer-menschen-mit-epilepsie/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/lexogen-releases-strand-specific-mrna-sequencing-kit/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/amgen-von-der-dna-ueber-biomarker-zu-individualisierter-medizin/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/vamida-erste-heimische-versandapotheke-geht-online/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/lisavienna-business-seminar-planung-und-durchfuehrung-von-klinischen-studien-fuer-medizinische-produk/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/boehringer-ingelheim-und-barofold-geben-strategische-vereinbarung-bekannt/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/oesterreichisches-parlament-gesundheitsausschuss-fuer-haftstrafen-bei-medikamentenfaelschungen/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/gsk-pneumokokken-impfung-in-oesterreich-gratis-fuer-alle-saeuglinge/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/gsk-fuehrt-beim-index-zugang-zu-medizin/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-vienna-encouraging-news-for-hip-surgeries-hip-prosthesis-developed-at-the-meduni-vienna-las/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/aws-business-angels-day-2012-werner-wutscher-zum-businessangel-of-the-year-gekuert/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/miracors-picsor-system-show-potential-to-treat-severe-heart-attack-stemi-patients/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/acib-eu-millionen-fuer-gruene-chemie-an-oesterreichisches-kompetenzzentrum/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/apeiron-biologics-estabishes-biotech-spinoff-attoquant-diagnostics/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-vienna-a-factor-involved-in-painful-joint-wear-and-tear-discovered/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-vienna-gene-therapy-as-a-new-option-for-bone-defects/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/pfizer-allianz-chronischer-schmerz-oesterreich-gegruendet/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-wien-peter-dubsky-am-san-antonio-breast-cancer-meeting/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/gsk-hofft-auf-nachhaltigere-produktion-durch-eu-projekt-mit-acib/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/bmwf-18-millionen-euro-fuer-die-erforschung-von-alzheimer-und-anderen-neurodegenerativen-erkrankunge/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/imp-two-imp-scientists-join-embo-young-investigator-programme/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/pharmig-arzneimittelfaelschungen-sind-ein-globales-thema/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/imba-juergen-knoblich-receives-erwin-schroedinger-prize-2012/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/aws-10-jahre-austria-wirtschaftsservice-ueber-63000-projekte-von-der-idee-bis-zum-markterfolg-unte/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/imp-a-key-gene-for-brain-development/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-wien-200-jahre-institut-fuer-pathologie-in-wien/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/cemm-identifies-fundamental-gene-silencing-mechanism/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/pdc-biotech-gmbh-announces-successful-clinical-phase-i-for-its-lead-compound-pdc31/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/gsk-und-vodafone-fuer-besseres-impfservice-von-kindern-in-mosambik/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/dutalys-enters-research-collaboration-with-a-top-ten-global-pharmaceutical-company/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/proposed-merger-of-equals-between-vivalis-and-intercell/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/gsks-einsatz-fuer-mehr-lebensqualitaet-in-europa/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/miracors-picsor-system-is-used-for-the-first-time-under-ce-mark-in-uk-to-treat-an-acute-heart-attac/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/aktuelle-zit-studie-zeigt-frauenfoerderung-wirkt/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/nationalstiftung-investiert-mehr-als-70-millionen-euro-in-oesterreichische-forschung/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/intercell-receives-chmp-positive-opinion-for-the-pediatric-indication-of-its-japanese-encephalitis-v/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/imba-ausweg-aus-der-blutarmut/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/fwf-erhaelt-182-mio-euro-von-der-nationalstiftung/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/gsk-baeckt-fuer-sozialtherapeutische-maedchen-wg-knapp-100-kg-selbstgebackene-weihnachtskekse/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/lieferung-von-fsme-impfstoff-durch-novartis-verzoegert-sich/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/bmg-stoeger-2013-wird-ein-gutes-jahr-fuer-patientinnen-und-patienten/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/evotec-and-apeiron-biologics-announce-collaboration-on-cancer-immunotherapy/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/bmwfj-mitterlehner-junge-high-tech-unternehmen-staerker-denn-je-unterstuetzt/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/pharmig-pharmaindustrie-53-neue-arzneimittel-in-europa-39-in-den-usa-im-jahr-2012/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/pharmaselect-startet-den-vertrieb-von-arzneimitteln-in-russland/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/gsk-diskusr-app-fuer-asthma-und-copd-patientinnen/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/fopi-wechsel-an-der-spitze-der-innovativen-arzneimittelhersteller/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/hookipa-thomas-monath-and-farshad-guirakhoo-join-hookipa-biotech-as-cmo-and-cso/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/hookipa-announces-formation-of-scientific-advisory-board/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/kav-neues-schilddruesenzentrum-in-der-rudolfstiftung/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/aws-reduziert-garantieentgelte-fuer-gruender-und-kmu-um-ein-drittel/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-wien-aktuelle-studie-kein-erhoehtes-allergierisiko-durch-genmodifizierte-erbsen/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/msd-liefert-update-ueber-die-naechsten-schritte-fuer-tredaptiver-nicotinsaeurelaropiprant/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/cemm-foot-soldiers-of-the-immune-system/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/astellas-uro-onkologische-forschung-auf-den-punkt-gebracht/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-wien-neue-prize-prototypenfoerderung-erstmals-vergeben/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/sanochemia-unterzeichnet-vorvertrag-mit-us-partner-fuer-vertrieb-von-kontrastmitteln-in-nordamerika/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/uni-wien-erfolgreiche-nachwuchswissenschafterinnen/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/imp-scientists-shed-light-on-the-dark-matter-of-dna/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-wien-rheuma-medikament-wirkt-auch-bei-halbierter-dosis/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/pharmig-pharmaindustrie-forscht-staerker-als-je-zuvor-im-kampf-gegentropenkrankheiten/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/apeptico-granted-orphan-drug-designation-by-ema-and-fda/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/imp-a-molecular-assembly-line-brings-muscles-into-shape/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/apeiron-closes-regional-licese-agreement-for-antibody-based-immunotherapy/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/vetmeduni-vienna-enzym-das-krebs-wachsen-laesst-steuert-auch-immunsystem/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/pfizer-unterstuetzt-patientenorganisationen-und-selbsthilfegruppen/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/gsk-gemeinsam-gegen-vernachlaessigte-tropische-krankheiten/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/fh-campus-wien-frauen-in-die-technik-infotag-am-281-an-der-fh-campus-wien/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/mfpl-immune-biologist-identifies-new-switch-in-immune-response/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/mfpl-minister-of-science-research-and-president-of-the-austrian-science-fund-fwf-visit-the-mfpl/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/tu-wien-tierische-schilddruesen-entlarven-atomtests/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/aws-phoenix-2013/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/gsk-100000-pfund-fuer-life-sciences-wettbewerb/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/arab-health-2013-in-dubai/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/wolf-theiss-advises-zytoprotec-on-baxters-investment/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/eans-news-intercell-ag-intercell-und-vivalis-geben-update-ueber-fortschritte-des-beabsichtigen-mer/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/zytoprotec-raises-eur-2-million-in-financing-from-baxter-ventures/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/mfpl-how-yeast-deals-with-stress/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/akh-wien-quantensprung-in-der-tumorbehandlung-akh-wien-startet-2013-personalisierte-krebstherapie/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/premiqamed-alternative-zu-konventioneller-colonoskopie-koennte-1000-oesterreicher-vor-dickdarmkrebs/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/pharmig-pharmazeutische-industrie-unterstuetzt-kassenkonsolidierungskurs/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/sanova-drei-jahre-rezeptfreie-abgabe-der-pille-danach/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/pfizer-weltkrebstag-2013-pfizer-investiert-mehr-als-20-prozent-seines-forschungsetats-in-krebsmed/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/pharmig-weltkrebstag-vom-todesurteil-zur-chronischen-erkrankung/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/boehringer-ingelheim-start-des-weltweiten-wettbewerbs-transforming-health-systems/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/tu-wien-von-maeuse-und-menschenhirnen/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/sanochemia-stabiles-basisgeschaeft-trotz-schwieriger-rahmenbedingungen/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/apeptico-releases-significant-scientific-results-of-its-industry-academia-collaboration-network/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/fopi-geeignete-rahmenbedingungen-fuer-pharmazeutische-innovation-schaffen/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/bmwf-karlheinz-toechterle-wertvoller-beitrag-durch-exzellente-forschung-heimischer-wissenschaftler/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/vienna-university-of-technology-nanostructures-with-living-cells/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/gsk-sponsert-ago-austria-young-scientific-award/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/oeaw-schreibt-2013-zwei-neue-forschungspreise-und-ein-neues-stipendium-aus/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/gsk-ergebnisse-2012-pound63-mrd-an-aktionaere/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/pharmaselect-neues-produkt-aronta-tabletten-gegen-chronische-innere-augenentzuendung-uveitis/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/stadt-wien-wiener-wirtschaftsfoerderung-wirkt/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/intercell-announces-pediatric-approval-of-its-japanese-encephalitis-vaccine-in-europe/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/lohmann-rauscher-wundversorgung-verbindet-lr-zeigte-neuheiten-auf-der-cpc-in-paris/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/lohmann-rauscher-international-noch-staerker-aufgestellt-lr-eroeffnet-neues-branch-office-in-sao/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/miracor-granted-five-additional-us-patents-and-one-additional-european-patent-for-its-picsor-syste/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/vetmeduni-vienna-erhaelt-europaweite-akkreditierung/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/univieboku-nanomachines-for-bionic-proteins/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/janssen-cilag-pharma-umfrage-untersucht-das-leben-von-psoriasis-patienten/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/tu-wien-biomasse-als-basis-fuer-hoch-wertgeschoepfte-neue-produkte/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/sanochemia-mit-positivem-start-in-das-geschaeftsjahr-20122013/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/cemm-research-institute-for-molecular-medicine-and-university-dep-of-paediatrics-adolescent-medic/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/the-2013-cemm-phd-program/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/syskids-3rd-meeting-excellent-cooperations-and-all-projects-in-time/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/pharmig-klinische-forschung-panikmache-durch-falschaussagen/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/fh-campus-wien-und-3m-starten-forschungskooperation/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/ccri-krebs-bei-kindern-steigende-heilungsraten-erfordern-verbesserte-therapien-und-nachsorge/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/ait-ehealth2013-begruesst-den-ehealth-summit-austria/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-wien-influenza-impfung-fuer-alle-altersgruppen-ratsam/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/gsk-unterstuetzt-die-alltrials-kampagne/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/baxter-wirtschaftsminister-mitterlehner-besucht-baxter/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/gsk-zahlung-an-patientenorganisationen-online/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-vienna-unsolved-puzzle-in-hepatology-on-the-brink-of-resolution/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-vienna-liver-cancer-treatment-can-be-determined-with-even-greater-precision/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/esr-brennpunkt-bildgebung-follow-up-bei-brustkrebs-in-oesterreich/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/tu-wien-maskierte-schimmelpilzgifte/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/pfizer-tag-der-seltenen-erkrankungen-28022013/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/esr-brennpunkt-bildgebung-multiple-sklerose-neue-erkenntnisse-und-update/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/intercell-extraordinary-general-meeting-approved-merger-of-equals-with-vivalis-sa-to-create-valneva/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/janssen-cilag-pharma-gmbh-aktuelle-umfrage-digitale-patientinnen/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/pharmig-rare-disease-day-erhoehte-forschungstaetigkeit-erweitert-behandlungsoptionen/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-vienna-researches-interferon-free-treatment-for-hepatitis-c/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/msd-erhaelt-eu-zulassung-fuer-isentressr-raltegravir-zur-kombinationstherapie-bei-hiv-1-infizierte/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/lundbeck-erhaelt-zulassung-fuer-selincror-zur-behandlung-der-alkoholkrankheit/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/mfpl-tipping-the-balance-of-signaling-pathways/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/gsk-weltweite-praevention-fuer-gsk-mitarbeiterinnen/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/pharmig-gratuliert-generikaverband-praesident-leiter-zur-wiederwahl/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/oegv-leiter-als-oegv-praesident-bestaetigt/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-wien-tumordiagnostik-neue-methode-macht-komplexe-biochemische-veraenderung-einzelner-zellen/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-vienna-vienna-scientists-observe-development-of-brain-pathways-even-in-the-womb/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/sigmapharm-weltneuheit-erster-nasenspray-gegen-influenza/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/mfpl-on-the-trail-of-mucus-eaters-in-the-gut/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/vienna-university-of-technology-the-heart-in-the-petri-dish/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-wien-knochenmetastasen-neue-schmerztherapie-soll-lebensqualitaet-und-lebenserwartung-verbess/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/marinomeds-antiviral-nasal-spray-approved-for-use-in-canada/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/apeiron-positive-outcome-in-clinical-study-to-prevent-radiation-induced-dermatitis-in-breast-cancer/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/intercell-ag-announces-q4-and-preliminary-full-year-2012-financial-results-and-business-update/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-wien-inventum-2012-silber-fuer-patent-der-meduni-wien/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/cemm-setting-the-foundation-to-map-the-proteome/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/esr-brennpunkt-bildgebung-schmerzen-durch-radiologie-lindern/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-wien-bei-schlaganfaellen-zaehlt-jede-minute/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/pharmig-health-care-symposium-die-gesundheitsreform-nimmt-gestalt-an/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/amgen-update-nierenerkrankungen-personalisierte-medizin-als-therapieoption-der-zukunft/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/oevih-fakten-zum-thema-pneumokokken-wie-gefaehrlich-sind-sie-wirklich/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/activartis-receives-orphan-drug-designation-for-its-cancer-immune-therapy-av0113/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/aws-starker-start-fuer-den-aws-gruenderfonds/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/intercell-vivalis-sa-shareholders-approved-the-proposed-merger-of-equals-to-create-valneva-se/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/oegmbt-forschungspreisausschreibung/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/siemens-ag-europapremiere-fuer-das-erste-kabellose-ultraschallgeraet-der-welt/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/imba-mutated-gene-causes-nerve-cell-death/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/gsk-auf-der-life-science-success-2013/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/lisavienna-business-seminar-entwicklung-und-vertrieb-von-software-und-apps-im-gesundheitsbereich/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/stadt-wien-moderne-erstversorgung-im-wilhelminenspital-positive-erste-bilanz/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-vienna-breast-cancer-treatment-halts-bone-metastases-and-also-protects-bones/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/bayer-inside-bayer-das-neue-aerzteportal-von-bayer-fuer-den-medizinischen-fachkreis/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/uni-wien-empfinden-fuer-schoenheit-bleibt-trotz-alzheimer-erhalten/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/momo18-mhealth-be-the-ceo-of-your-own-health/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/lexogen-announces-the-win-your-sense-study-award/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/oeaw-anton-zeilinger-neuer-praesident-der-oeaw/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/marinomed-antiviral-nasal-spray-data-from-two-clinical-studies-prove-effectiveness/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/gsk-oesterreich-stellt-sich-ethik-assessment/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/two-pi-selffit-references-hearing-aid-market-trends/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/pfizer-lungenkrebsdiagnostik-gewinnt-an-bedeutung/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-vienna-faulty-gene-regulation-triggers-kidney-disease-fsgs/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/gsk-unterstuetzt-eu-plattform-mundgesundheit/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/vetmeduni-vienna-dreimal-krebsforschungspreis-der-stadt-wien-fuer-das-team-sexl/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/aop-orphan-essential-thrombocythemia-et-convincing-data-of-anahydret-study-now-published/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/sanochemia-us-patent-fuer-verbessertes-syntheseverfahren-zur-herstellung-von-hochreinem-galantamin/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/stadt-wien-gentechnik-sima-laedt-zu-hintergrundgespraech-zu-rattenstudie-mit-prof-seralini/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/pharmig-begruesst-initiative-des-hauptverbands-zur-therapietreue/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/baxter-sponsert-erste-hilfe-raum-fuer-obdachlose-in-der-gruft/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/univie-novel-insights-into-the-evolution-of-protein-networks/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/semperit-ag-holding-rekordumsatz-und-zweitbester-jahresueberschuss-der-firmengeschichte-im-geschaefts/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/cemm-adjunct-pi-thijn-brummelkamp-identified-entrance-mechanism-of-the-lassa-virus-into-cells/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/gsk-viiv-healthcare-kuendigt-lizenzvereinbarung-an-um-zugang-zu-hiv-medikamenten-fuer-kinder-zu-erhoe/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/stadt-wien-staedteindex-wien-als-innovativste-stadt-europas/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/stadt-wien-brauner-top-ranking-wiens-bestaetigt-innovations-foerderungen-der-stadt/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/vetmeduni-vienna-wissenschafts-und-forschungsminister-karlheinz-toechterle-besuchte-vetmeduni-vienn/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/miracor-successfully-completes-first-german-patient-using-the-picsor-system/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/amex-gmbh-gewinnt-spitalsprojekt-in-sofia-bulgarien/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/acib-indian-industry-trusts-in-biotech-research-from-graz/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/themis-bioscience-new-infectious-diseases-successful-vaccine-developments-at-themis-bioscience/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/kwizda-pharma-was-die-natur-hat-hat-biogelatr/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/mfpl-recombination-needs-timing/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/mfpl-gernot-walko-receives-marie-curie-fellowship/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-wien-impfung-gegen-schnupfen-ist-denkbar/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/merck-staerkt-standort-wien/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/pharmig-patentschutz-unterstuetzt-die-entwicklung-innovativer-arzneimittel/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/vamed-bilanz-2012-historische-bestwerte/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-wien-entwickelt-europaweite-pollenflug-belastungslandkarte/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/solvo-partners-with-ait-to-represent-its-small-animal-molecular-imaging-services-worldwide/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/mfpl-update-on-next-generation-benchtop-sequencing/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/s-target-achieves-in-vivo-proof-of-concept-for-its-allergy-vaccine-sg100/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/sanochemia-dr-biermayer-ist-neuer-geschaeftsfuehrer-bei-sanochemia-tochter-alvetra/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/tu-wien-bessere-pharmaprodukte-aus-lebenden-zellen-neues-cd-labor/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/cdg-neues-doppler-labor-fuer-arzneimittel-aus-zellen/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-wien-apherese-blutwaesche-hocheffiziente-therapieoption-mit-enormem-potenzial/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/boehringer-ingelheim-regional-center-vienna-rcv-baut-standort-wien-weiter-aus/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/activartis-early-results-of-av0113-cancer-immunotherapy-in-glioblastoma-trial-reveal-promising-tren/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/sondierungsreise-zur-conhit-nach-berlin/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/wifo-zieht-positive-bilanz-zu-biotechnologie-patenten-in-oesterreich/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/pharmig-pharmazeutische-industrie-unterstuetzt-wesentlich-das-finanzplus-der-krankenkassen/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-vienna-discovery-of-genetic-defect-which-triggers-epilepsy/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-vienna-hpv-vaccination-to-provide-even-more-protection-in-future-against-infections/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/pfizer-welthaemophilietag-17-april-2013/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/oegv-generika-senken-arzneimittelausgaben/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/fh-campus-wien-neue-aufnahmeverfahren-fh-alternativen-zu-ueberlaufenen-uni-studien/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/lisavienna-biotech-delegation-from-luxembourg-visits-life-science-location-vienna/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/apeptico-initiates-phase-ii-clinical-trial-with-ap301/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/baxter-zweiter-soehne-tag-baxter-schliesst-info-luecke-fuer-buben/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/bc-industrie-holding-oesterreichischer-star-immunologe-penninger-haelt-keynote-beim-houskapreis/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/aws-diskussionsveranstaltung-das-bringt-das-neue-eu-patent-der-oesterreichischen-wirtschaft/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/lisavienna-lisavienna-biotech-delegation-from-luxembourg-visits-life-science-location-vienna/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/wko-15-oesterreichische-firmen-auf-weltleitmesse-des-biotech-sektors-in-chicago/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/aws-risikokapital-stuetzt-wachstum-von-innovativen-klein-und-mittelbetrieben/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/gsk-nachhaltigstes-pharmaunternehmen-2012/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/vetmeduni-vienna-a-surprising-new-function-for-small-rnas-in-evolution/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/astrid-launches-its-free-digital-biobank-system-to-accelerate-personalized-medicine-research/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/siemens-ag-estro-forum-vom-19-bis-23-april-2013-in-genf/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/vienna-university-of-technology-the-bees-knees-for-detecting-disease/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/novartis-caritas-socialis-partnerschaftstag-2013/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/intercell-eans-hinweisbekanntmachung-intercell-ag-jahresfinanzbericht/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/boehringer-ingelheim-setzte-wachstumsphase-im-geschaeftsjahr-2012-konsequent-fort/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/boehringer-ingelheim-rcv-erfolgreiche-produkteinfuehrungen-sichern-wachstum-in-oesterreich-und-cee-re/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/mfpl-flu-and-bacteria-better-prognosis-for-this-potentially-fatal-combination/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/pharmig-gesundheitsreform-chance-zur-veraenderung/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/oesterreichisches-patentamt-praesident-roedler-oesterreichisches-biopatent-monitoring-einzigartig-in-e/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/vetmeduni-vienna-neuer-universitaetsrat-fuer-die-veterinaermedizinische-universitaet-wien/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/ait-internationale-spitzenforscher-referieren-am-ait/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/mfpl-debunking-misconceptions-about-viral-infection/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/uni-wien-zwei-hohe-internationale-auszeichnungen-fuer-mikrobiologen-michael-wagner/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/pharmig-praevention-einreichfrist-beim-gremium-gesundheitsziele-beginnt-morgen/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/haus-d-barmherzigk-diskussionsforum-pflege-zwischen-technischen-moeglichkeiten-und-moralischer-not/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/uni-vienna-computer-simulations-reveal-the-energy-landscape-of-ion-channels/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/agfa-healthcare-neue-impax-ee-client-version-r20-xii-verfuegbar/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-vienna-gene-mutation-as-cause-of-breast-and-ovarian-cancer/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/stadt-wien-haeupl-kooperation-wien-hamburg-unterzeichnet/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/bmwf-minister-toechterle-und-oeaw-praesident-denk-8-millionen-euro-fuer-innovative-nachwuchsforscheri/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/vetmeduni-vienna-messerli-forschungsinstitut-eroeffnet-neues-labor-fuer-komparative-medizin/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/cemm-adjunct-pi-thijn-brummelkamp-receives-the-embo-gold-medal-2013/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/lundbeck-abilify-jetzt-neu-bei-lundbeck-austria/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/vetmeduni-vienna-sonja-hammerschmid-als-rektorin-der-vetmeduni-vienna-wiedergewaehlt/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-vienna-effective-vaccination-against-borreliosis-possible/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/gsk-neue-partnerschaft-gsk-und-save-the-children/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/boku-ranking-erfolg-fuer-boku/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/gsk-impfstoffe-als-lebensretter-nr/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/intercell-merger-between-intercell-and-vivalis-planned-to-complete-on-may-28-2013/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/lohmannrauscher-ewma-positionspapier-empfiehlt-debrisoft-fuer-schnelles-schmerzarmes-effektives-d/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/lohmann-rauscher-rosidalr-tcs-im-praxistest-auf-dem-deutschen-wundkongress-2013-in-bremena/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/prd-gute-nase-fuer-public-relations-prd-punktet-bei-drei-erfolgreichen-wiener-biotech-firmen/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/lohmann-rauscher-mit-debrisoftr-schnell-und-schmerzarm-debridieren/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/okids-geht-an-den-start/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/pharmig-pharmazeutische-industrie-co-finanziert-forschungsnetzwerk-fuer-kinderarzneimittel/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/aop-orphan-elan-announces-transactions-decisively-transforming-the-company/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/intercell-announces-pediatric-approval-of-its-japanese-encephalitis-vaccine-in-the-us/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/bmwf-investitionen-in-forschung-und-entwicklung-erreichen-rekordwert-von-9-milliarden-euro/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/ffg-senkt-darlehenszinsen-in-den-basisprogrammen-erneut/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/wkoe-verlinkt-oesterreichische-biotech-firmen-mit-britischen-partnern/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-vienna-fascinated-with-anatomy-amazing-models-in-viennas-josephinum/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/pharmig-internat-pharmazeutische-industrie-schafft-awareness-fuer-psychische-und-neurologische-erkr/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/mfpl-1-million-euro-ffg-funding-to-boost-structural-biology-research/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/gskgavi-hpv-impfstoff-fuer-maedchen-in-3-welt/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/welldone-gmbh-bedeutung-von-allergien-fuer-die-entwicklung-einer-asthma-erkrankung/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/gsk-flyer-pneumologische-rehabilitation/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-vienna-treatment-of-cervical-pre-cancer-suppository-developed-against-hpv-induced-changes/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/mfpl-innovation-luminary-award-for-alexander-von-gabain/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/pfizer-austria-bietet-beratung-zur-raucherentwoehnung/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/astellas-wirtschaftskiller-schmerz/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/pharmig-fordert-konsequentes-engagement-bei-tabakpraevention/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/valneva-international-biotech-company-valneva-starts-trading-on-the-prime-market-of-the-vienna-se/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/valneva-completion-of-merger-between-vivalis-and-intercell-to-form-valneva/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/mfpl-what-is-the-synaptonemal-complex/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/pharmig-arzneimittelforschung-ist-transparent-und-hohen-ethischen-standards-verpflichtet/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/gsk-ist-neues-mitglied-von-transparency-austria/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/ffg-zwischenevaluierung-bestaetigt-laura-bassi-centres-of-expertise/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/vienna-university-of-technology-molecular-switch-for-cheaper-biofuel/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/semperit-ag-holding-semperit-owns-more-than-95-of-latexx-partners-delisting-from-bursa-malaysia/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/lisavienna-life-science-delegation-visit-to-china-and-south-korea/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/imba-the-fight-against-genome-parasites/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/bmwf-karlheinz-toechterle-spricht-sich-fuer-weitere-staerkung-des-wissenstransfers-aus/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/mysugr-launches-in-the-us-and-gets-ferris-on-board/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/aws-start-up-day-2013-zeigt-erfolgsgeschichte-der-preseed-foerderung/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/ait-geht-mit-gutem-ergebnis-2012-in-die-zukunft/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/valneva-se-announces-the-sale-of-its-clinical-manufacturing-operations-cmo-in-france-to-biological/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/fh-technikum-wien-erste-medtec-summer-academy-startet-in-20-tagen/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/vetmeduni-vienna-painting-by-numbers/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/fh-technikum-wien-informative-and-festive/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/bmwf-karlheinz-toechterle-oesterreich-und-cern-intensivieren-kooperation/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/sanochemia-zulassungseinreichung-in-amerika-fuer-mr-kontrastmittel/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/oesterreichische-apothekerkammer-apotheker-begruessen-initiative-fuer-mehr-arzneimittelsicherheit/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-wien-kardiologenpreis-basic-sciene-wolfgang-denk-preis-der-gesellschaft-fuer-herz-thoraxchi/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-vienna-functional-mri-provides-support-in-operations-on-the-brain/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/ffg-oesterreichs-system-der-forschungsfoerderung-ist-top-im-internationalen-benchmark/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/ffg-foerderungen-stark-nachgefragt-unis-wollen-staerker-mit-wirtschaft-kooperieren/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/valneva-announces-launch-of-fully-underwritten-eur40-mill-capital-increase-with-preferential-subscript/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/boehringer-ingehlheim-rcv-wechsel-in-der-geschaeftsfuehrung-im-boehringer-ingelheim-regional-center-v/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/mfpl-bringing-science-closer-to-the-public/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/aop-orphan-spins-off-its-stake-in-activartis-and-outlines-business-strategy/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/two-pi-selffit-technology-links-to-tomorrows-hearing-healthcare/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-wien-christine-mannhalter-als-vizepraesidentin-im-fwf-praesidium-bestaetigt/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/bmwfj-mitterlehner-junge-biotech-unternehmen-staerker-foerdern-seltene-krankheiten-besser-erforsche/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/pfizer-die-kultpille-von-pfizer-feiert-geburtstag/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-vienna-develops-new-technologies-for-retinal-therapies/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-wien-netzwerk-von-protein-kinasen-steuert-die-bildung-des-raeumlichen-gedaechtnisses/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/baxter-simone-oremovic-ist-human-resources-director-bei-baxter-oesterreich/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/bmwf-phoenix-2013-verliehen/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/wkw-mercur-2013-einreichfrist-fuer-innovationspreis-beginnt-jetzt/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-wien-parkinson-ohne-zittern/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/stadt-wien-wiener-wirtschaftsfoerderung-setzt-verstaerkt-auf-naehe-und-ferne/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/vetmeduni-vienna-neues-cd-labor-an-der-vetmeduni-vienna-eroeffnet/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-wien-uni-ranking-meduni-wien-beste-heimische-jung-uni/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-wien-pet-studie-knackt-das-geheimnis-von-therapieresistenzen-bei-epilepsie-patientinnen/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/themis-bioscience-impfstoffspezialist-gewinnt-renommierte-mitglieder-fuer-aufsichtsrat/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/1-fopi-stakeholderdialog-thematisiert-verantwortung-im-gesundheitswesen/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/gsk-zeigt-soziale-verantwortung-rechnet-sich/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/mfpl-lifes-rhythms/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/pharmig-klinische-studien-forschung-mit-und-fuer-menschen/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/boehringer-ingelheim-sobi-erhaelt-fda-zulassung-zur-herstellung-von-kineretr/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-vienna-wave1-identified-as-key-protein-in-sepsis/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-wien-neue-hoffnung-fuer-menschen-mit-ueberaktiver-blase/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/baxter-sozialminister-hundstorfer-besucht-gesundheitsunternehmen-baxter/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-vienna-amphetamines-only-work-when-well-lubricated/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/imba-10-jahre-imba-karlheinz-toechterle-lebenswissenschaften-im-besten-sinn-des-wortes/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/mfpl-illuminating-the-brain/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/ait-liefert-neue-impulse-in-der-krebsforschung/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/lisavienna-business-seminar-in-cooperation-with-uk-trade-investment-and-the-british-embassy-vienna/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/pharmig-arzneimittelfaelschungen-verhindern-die-pharmaindustrie-setzt-massnahmen/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/ottobock-erweitert-unternehmensstandort-wien-spatenstichfeier-und-neues-fertigungsgebaeude/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/tu-wien-ressel-preis-2013-die-suche-nach-dem-optimalen-pilz/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/gsk-nachahmenswerte-soziale-gesundheitsprojekte/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/cemm-macrophages-and-their-control-system/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/tu-austria-sabine-seidler-ab-1-juli-neue-praesidentin/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/imp-new-scientific-directorate-at-the-research-institute-of-molecular-pathology-in-vienna/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/imba-direction-matters-es-kommt-auf-die-richtung-an/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/pharmig-zu-stoeger-schritte-in-die-richtige-richtung/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/pharmig-pharmazeutische-industrie-ist-der-transparenz-und-ethischen-werten-verpflichtet/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-vienna-stress-induced-overweight-mechanism-for-fat-distribution-discovered/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/valneva-se-announces-the-successful-completion-of-its-eur40-million-capital-increase/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/lohmann-rauscher-15-jahre-medizinprodukte-von-lohmann-rauscher-lr/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/vetmeduni-vienna-das-kompetenz-projekt-pvm-praeventive-veterinaermedizin-lud-zum-stakeholder-meetin/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/apeptico-accelerates-its-clinical-development-program-with-a-research-grant-from-the-ffg/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/miracor-miracor-appoints-senior-medical-device-expertdr-werner-braun-to-its-board-of-directors/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/baxter-bundeskanzler-faymann-besucht-baxter/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/uni-wien-warum-uebertriebene-abwehr-gegen-krankheiten-evolutionsbiologisch-sinn-macht/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-vienna-heart-failure-new-treatment-option-makes-heart-softer/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/vetmeduni-vienna-on-the-trail-of-bacteria/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/lisavienna-delegation-visit-of-the-adt-to-the-vienna-life-science-cluster/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/marinomed-pharma-company-acquires-rights-to-antiviral-product-line-for-china/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/valneva-se-announces-a-new-eb66r-cell-line-research-license-agreement-with-boehringer-ingelheim/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-vienna-brain-surgery-simulator-in-use-at-the-meduni-vienna/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/mfpl-putting-a-brake-on-chromosome-breaks/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/imp-five-erc-starting-grants-for-researchers-at-imp-and-imba/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/tu-wien-allheilmittel-oder-fehlverschreibung-wie-e-health-und-co-unser-leben-veraendern/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-vienna-factor-for-impaired-immune-response-in-pneumonia-identified/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/apeptico-wiener-forscher-arbeiten-an-arznei-gegen-akutes-lungenversagen/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/uni-wien-zwei-hochdotierte-erc-starting-grants-fuer-forscherinnen-der-universitaet-wien/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/mfpl-erc-starting-grant-for-kristin-tessmar-raible/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/vetmeduni-vienna-the-hair-of-the-dog/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/imba-fussball-kann-heilen-kooperation-fk-austria-wien-mit-imba-und-debra-austria/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/bmwf-karlheinz-toechterle-erfreulicher-beleg-der-exzellenten-nachwuchsforscherinnen-am-standort-oes/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/mfpl-keeping-centrioles-in-check-to-ensure-proper-cell-division/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/valneva-se-biological-es-japanese-encephalitis-vaccine-prequalified-by-the-world-health-organizat/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/vetmeduni-vienna-deutscher-studienpreis-2013-zweiter-preis-fuer-benz-schwarzburg/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/tu-wien-innovative-technologien-fuer-die-altenpflege/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/neue-foerderung-der-wirtschaftsagentur-wien-standortinitiative/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/gsk-hepatitis-kennen-und-die-stirn-bieten/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/ffg-buresmitterlehner-75-millionen-euro-zur-staerkung-des-kompetenzstandortes-oesterreich/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/business-angel-institute-erste-zertifizierte-business-angels-ab-herbst/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-vienna-trigger-for-wheat-allergy-discovered/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-vienna-new-approach-in-the-treatment-of-breast-cancer/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/imba-three-imba-researchers-receive-erc-grants/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/pharmig-lebenserwartung-von-90-jahren-im-jahr-2050-wahrscheinlich/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-vienna-estimating-the-risk-of-bowel-cancer/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/semperit-ag-holding-best-half-year-results-ever-despite-weak-economy/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/imp-a-skeleton-for-chromosomes/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/cemm-and-haplogen-make-available-the-worlds-largest-collection-of-engineered-human-cell-lines-for-b/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/imba-brains-on-demand-scientists-succeed-in-growing-human-brain-tissue-in-test-tubes/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-vienna-precise-monitoring-of-heart-pumps-makes-personalised-medicine-possible/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/arsanis-inc-closes-20-million-series-b-financing/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/evercyte-and-vela-laboratories-announce-cooperation-to-provide-immortalized-cell-lines-for-biosimila/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/pfizer-im-internationalen-einsatz-gegen-pneumokokken-erkrankungen/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/inits-messen-statt-schaetzen-sichere-gehirnoperation-dank-wiener-start-up-cvtec/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-vienna-lifetime-of-transplanted-kidneys-can-be-significantly-prolonged/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/lisavienna-bio-europer-2013-program-is-packed-with-well-known-dealmakers/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-vienna-even-better-performance-from-donor-lung/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/msd-toechterle-und-jank-besuchen-msd-produktionsstandort-in-wien/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/astellas-xtandir-enzalutamid-neues-medikament-fuer-das-fortgeschrittene-prostatakarzinom-ab-so/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/campus-vienna-biocenter-ohne-masterplan-zur-spitze/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/vetmeduni-vienna-static-killers/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-vienna-genetic-make-up-of-rare-gastrointestinal-tract-tumour-decoded/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/tu-wien-neue-kombinationen-bildgebender-verfahren-fuer-die-biowissenschaft/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-vienna-new-even-more-effective-hpv-vaccine-in-sight/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/gsk-gibt-eu-einreichung-fuer-cervarixr-2-dosen-schema-bekannt/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/kapsch-to-support-the-st-anna-childrens-cancer-research-institute/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/boku-die-zufriedensten-studierenden-oesterreichs/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/ludwig-boltzmann-gesellschaft-13-september-ist-welt-sepsis-tag-und-wien-zurzeit-zentrum-fuer-europa/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/gsk-dabrafenib-in-der-eu-zugelassen/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/nabriva-therapeutics-presented-data-on-potency-safety-tolerability-and-pharmacokinetics-of-pleurom/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-vienna-researching-the-causes-of-vivax-malaria-in-ethiopia/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/bmwf-hochschulraum-strukturmittel-karlheinz-toechterle-48-millionen-euro-fuer-gezielte-kooperation/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-vienna-life-without-fits-new-treatment-for-refractory-epilepsies/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/vetmeduni-vienna-getting-rid-of-unwanted-visitors/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/vetmeduni-vienna-personality-differences-in-lean-times-red-deer-with-dominant-personalities-pay-a/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-vienna-research-into-ageing-more-diseases-are-responsible-for-dementia-than-previously-thou/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/lisavienna-klinische-entwicklung-von-arzneimitteln-in-oesterreich-biotech-meets-big-pharma/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-wien-katheter-technik-rettet-bei-schweren-schlaganfaellen-leben/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/merck-serono-innovationsfuehrer-bei-wachstumshormonen/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/bmwf-wissenschaftsminister-toechterle-und-wirtschaftsminister-mitterlehner-starten-wissenstransferze/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/aws-unterstuetzt-neue-wissenstransferzentren/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/wkw-internationalisierungsoffensive-go-international/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/apeiron-biologics-ag-collaborates-with-idis-ltd-to-initiate-managed-access-program/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/aws-zukunftsstrategie-auf-schiene/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/panoptes-pharma-4sc-discovery-and-panoptes-pharma-sign-patent-transfer-agreement-for-novel-compound/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/panoptes-pharma-successfully-closed-seed-financing-round-of-eur-12-million/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/bayer-weltverhuetungstag-2013-know-your-options/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/sanochemia-rosinger-group-verstaerkt-ihr-investment-in-sanochemia/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/vetmeduni-vienna-genes-against-parasites-an-african-breed-of-cattle-harbours-potential-weapons-ag/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/eucodis-successfully-manufactured-ferritin-at-industrial-pilot-scale-for-biaqua/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/fh-technikum-wien-erstes-josef-ressel-zentrum-an-der-fh-technikum-wien-offiziell-eroeffnet/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/fwf-klif-iii-bringt-15-weitere-projekte-fuer-die-klinische-forschung-in-oesterreich/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/first-lisavienna-life-science-circle-at-the-university-of-applied-sciences-technikum-wien/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/tissuegnostics-wiener-medizintechnikunternehmen-tissuegnostics-expandiert-im-nahen-osten/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/inits-green-technology-blue-jeans-sanfte-enzyme-ersetzen-aggressive-chemie-bei-jeans-design/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/ages-neue-leitung-der-ages-medizinmarktaufsicht/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/diagnosia-millionenfinanzierung-fuer-diagnosia-google-fuer-aerzte-expandiert/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/vetmeduni-vienna-making-the-most-of-what-you-have/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-vienna-diabetes-personalised-therapy-reduces-the-risk-of-cardiovascular-disease/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-wien-in-der-rheumaforschung-weltweit-im-spitzenfeld/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/s-target-achieves-clinical-proof-of-concept-for-allergy-vaccine-sg100-in-asthmatic-non-human-primate/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/aop-orphan-pharmaceuticals-announces-progress-of-pivotal-phase-iii-trial-proud-pv-of-novel-mono-pegy/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/bmwf-toechterle-und-mitterlehner-starten-ausschreibung-der-wissenstransferzentren/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-vienna-multiple-sclerosis-functional-change-in-brain-as-cause-of-cognitive-disorders/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-wien-krampfadern-erhoehen-das-risiko-fuer-venenthrombosen-oder-lungenembolien-bei-krebspatient/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/vrvis-forscherteams-von-vrvis-und-jku-bei-international-wichtigster-konferenz-fuer-visualisierung-me/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/lisavienna-current-study-on-life-sciences-in-vienna/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/pfizer-initiative-get-old-fuer-gesundes-und-aktives-altern-startet/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/gsk-studienergebnisse-zu-malariaimpfstoff-fuer-kinder/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/apeptico-announces-a-licensing-agreement-for-pepbasetm-with-chem-tech-research-incorporation-c-tr/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/imp-a-trace-of-memory/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/pharmig-klinische-studiendaten-sind-kein-kochrezept/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-vienna-lithium-in-drinking-water-reduces-suicide-rates-possibly-also-as-a-result-of-medici/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-wien-vorzeitige-umstellung-des-schlaf-rhythmus-hilft-gegen-mini-jetlag-bei-winterzeit/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/novo-nordisk-tauscht-3-chargen-von-novomixr-30-flexpenr-in-oesterreich-aus/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/zytoprotec-wiener-zytoprotec-zieht-baxter-investment-an-land/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/tu-wien-entwickelt-den-weltweit-staerksten-terahertz-quantenkaskadenlaser/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/aop-orphan-partnership-between-aop-orphan-and-ferrer-joint-marketing-of-adasuver-in-cee/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/valneva-provides-update-on-phase-iiiii-interim-analysis-of-its-pseudomonas-aeruginosa-vaccine-candi/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/vogelbusch-argentinas-largest-ethanol-plant-commences-oparations/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/sanofi-aventis-sanofi-stiftung-zeichnet-salzburger-wissenschafter-aus/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/dla-piper-life-science-breakfast-bei-dla-piper/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/hookipa-biotech-closes-eur20-million-275-million-in-series-b-financing/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/tu-wien-grosser-erfolg-fuer-bio-projekte-der-tu-wien/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/lisavienna-key-european-biotech-partnering-conference-opens-in-vienna/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/sempermed-introduces-three-new-products-at-the-a-a-2013/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/savira-roche-takes-over-development-of-saviras-influenza-polymerase-inhibitor-programs/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/themis-bioscience-new-infectious-diseases/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/miracor-successfully-completes-enrollment-of-30-patients-in-a-safety-and-feasibility-study-using-i/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-vienna-7-tesla-mri-scanner-supports-research-into-multiple-sclerosis/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/msd-setzt-oesterreichweit-zahlreiche-initiativen-zum-welt-diabetes-tag-2013/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/diagnosia-die-sicherste-art-medikamente-zu-verschreiben-ist-nun-in-oesterreich-erhaeltlich/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/semperit-ag-holding-semperit-increases-revenue-and-result-in-q1-3-2013/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/baxter-haemophilie-b-baxter-beantragt-ema-zulassung-fuer-rekombinantes-faktor-ix-praeparat/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-vienna-diabetes-changes-in-lifestyle-can-prevent-illness-in-early-stages-developing-further/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/aws-100-millionen-eur-fuer-oesterreichs-start-up-szene/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/ait-ehealth-ante-portas-3-jahre-gesundheitsdialog-diabetes-der-vaeb/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-wien-und-land-niederoesterreich-kooperieren-bei-medaustron/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/stadt-wien-brauner-neue-jobchancen-durch-innovative-betriebe/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/ebd-group-bio-europer-2013-breaks-all-previous-records-for-attendance-and-partnering/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-wien-sanofi-stiftung-zeichnet-wiener-wissenschafterinnen-aus/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/mfpl-surprising-role-of-gene-regulator-protein-in-development-of-skin-tumors/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/vetmeduni-vienna-pharmakologin-agnes-dadak-erhaelt-inits-award-fuer-innovative-forschung/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/vetmeduni-vienna-researchers-find-protein-that-regulates-the-burning-of-body-fat/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-vienna-molecular-effectiveness-of-peptides-from-african-medicinal-plants-decoded/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-vienna-50-years-of-heart-surgery-mortality-rates-significantly-reduced-in-operations/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/lbg-wissenschaftler-mit-wilhelm-exner-medaille-ausgezeichnet/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/medica-2013/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/austromed-medizinprodukte-branche-zunehmend-heiss-umkaempfter-wachstumsmarkt/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/imba-molecular-glue-controls-chromosome-segregation-in-oocytes/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/imp-pushing-the-limits-of-light-microscopy/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-vienna-missing-brake-in-the-brain-can-trigger-anxiety-states/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/pharmig-113-millionen-euro-fuer-suchtpraevention-und-psychosoziale-gesundheit/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/apeptico-publishes-significant-scientific-results-of-its-development-compound-ap301/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/bmwf-11-millionen-euro-fuer-die-praevention-von-neurodegenerativen-erkrankungen/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-vienna-rheumatism-treatment-effective-even-when-the-use-of-biological-agents-is-slightly-de/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/tu-wien-neue-mikroskopie-methode-mit-farben-abstaende-messen/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/marinomed-effectiveness-of-marinomeds-antiviral-nasal-spray-confirmed-in-clinical-trial-for-common/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/lbg-grosser-erfolg-fuer-die-1-lbg-health-sciences-tagung/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/merck-foerdert-innovative-schuelerinnen-und-schueler-in-oesterreich/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/wkoe-geschaefts-und-exportchancen-im-gesundheitsbereich-fuer-unternehmen/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/fwf-und-oeaw-gemeinsam-fuer-eine-erfolgreiche-zukunft-oesterreichs/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/valneva-secures-usd-30m-new-financing-and-confirms-sale-of-clinical-manufacturing-operations-in-fran/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/modul-university-vienna-freie-bahn-zum-huerdenlauf-fuer-universitaere-spin-offs-in-wien/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/imba-ice-cold-methods-decode-bacterial-infection-systems/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/two-pi-fda-channels-hearing-aid-industry-innovation/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/profem-pilzinfektionen-bei-frauen-neue-chancen-zur-behandlung-einer-hartnaeckigen-erkrankung/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/ffg-startschuss-fuer-horizon-2020-erste-ausschreibungen-veroeffentlicht/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/abbvie-erforscht-neue-behandlungsmoeglichkeiten-fuer-hepatitis-c-patienten/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/vetmeduni-vienna-a-stop-sign-for-cancer/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/imp-a-molecular-toolkit-for-gene-silencing/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/cemm-discovery-in-vienna-brings-hope-to-millions-of-myeloproliferative-neoplasia-patients-worldwide/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/uniko-appell-keine-angelobung-der-regierung-ohne-wissenschaftsministerin/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/biomay-ag-successfully-completes-interim-analysis-of-phase-iib-study-with-the-innovative-3rd-generat/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/lbg-sieht-eingliederung-der-forschung-ins-wirtschaftsministerium-als-auftakt-zur-ressourcenbuendelung/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/tuev-austria-generationswechsel-beim-institut-fuer-medizintechnik-des-tuev-austria/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/boku-neues-christian-doppler-labor-mit-chanel-eroeffnet/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-vienna-the-first-biological-heart-valve-implanted-into-a-beating-heart/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/st-anna-kinderkrebsforschung-in-der-erfolgreichen-behandlung-von-kinderkrebs-ist-oesterreich-europae/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-vienna-infection-with-the-common-cold-virus/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-wien-schutzimpfungen-der-nutzen-ueberwiegt-bei-weitem/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/miracor-discloses-interim-data-demonstrating-a-strong-trend-toward-a-larger-infarct-size-reduction-a/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/sanochemia-finaler-jahresabschluss-201213/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/apeiron-signs-regional-license-agreements-for-the-commercialization-of-its-neuroblastoma-therapy/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/tissuegnostics-leading-vienna-medical-technology-company-tissuegnostics-establishes-its-position-in/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/bmwfj-mitterlehner-neue-prize-prototypenfoerderung-erstmals-vergeben/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/mfpl-intermediate-filaments-play-a-crucial-role-for-cytoskeleton-regulated-mechanosensing/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/gsk-neues-management-team-bei-gsk-oesterreich/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/gmi-michael-nodine-awarded-era-caps-grant-for-plant-embryology-project/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/philips-austria-kuenftig-unter-neuer-leitung/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/imp-fly-eye-wins-scientific-image-contest/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/baxter-welt-innovation-made-in-austria-hemopatch-zur-blutstillung-im-op/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/gmi-michael-nodine-receives-funding-for-rna-biology-phd-position/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/mfpl-not-just-clean-but-spotless/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/lisavienna-business-seminar-die-aspekte-der-technischen-dokumentation-fuer-gebrauchsanweisungen-von/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/affiris-gut-aufgestellt-mit-der-affiris-ag/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/bmwfj-mitterlehner-sechs-unternehmen-fuer-staatspreis-innovation-2014-nominiert/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-wien-egon-ogris-zum-inventor-of-the-year-gewaehlt/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/vetmeduni-vienna-here-comes-the-sun-how-vitamin-d-relaxes-blood-vessels/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/boku-curry-as-a-remedy-for-cancer/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/stadt-wien-innovationen-staerken-wiener-wirtschaft/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/bmwfj-mitterlehner-horizon-2020-staerkt-forschungsstandort-und-sichert-wettbewerbsfaehigkeit/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-wien-cd-labor-erforscht-potenzial-von-thiomeren-fuer-die-behandlung-des-trockenen-auges/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/gsk-erstes-2-dosen-impfschema-fuer-hpv-impfstoff/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/mfpl-brain-development-researchers-identify-key-protein/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-vienna-declares-war-on-congenital-disorders-of-the-immune-system/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/boku-grosser-erfolg-fuer-boku-im-greenmetric-university-ranking/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-wien-prostatakrebs-wiener-mediziner-entwickeln-hocheffizientes-mediakment-mit-globalen-part/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/nabriva-therapeutics-zit-grant-received-for-extended-spectrum-pleuromutilin-esp-program/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/pharmaselect-neues-medikament-cyrdanax-bei-brustkrebs/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-vienna-cannabis-consumption-during-pregnancy-can-impair-the-babys-brain-development/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/aws-chinas-technologieoffensive-wie-kann-sich-oesterreich-bei-innovation-und-geistigem-eigentum-pos/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/kh-der-barhmherzigen-schwestern-wien-patientennahe-forschung-zwischen-gastroenterologie-und-rheumat/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/fva-gemeinnuetzige-stiftungen-haetten-enormes-potenzial-fuer-forschung-und-zivilgesellschaft/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/bmwfj-mitterlehner-erfolgreiche-forschung-ist-basis-fuer-wettbewerbsfaehigkeit-innovationsfuehrersch/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/boehringer-ingelheim-wettbewerb-zu-kooperations-projekten-mit-sozialem-und-wirtschaftlichem-fokus/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/wkoe-chancen-und-veraenderungen-im-china-geschaeft-2014/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-vienna-not-smoking-can-prevent-or-improve-bladder-cancer/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/imp-foerdererfolg-fuer-wiener-life-science-forschung/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/bmwfj-mitterlehner-erweiterung-des-vienna-open-lab-ist-investition-in-die-zukunft-und-steigert-int/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/ait-im-dialog-telemedizin-im-dienste-der-gesundheit/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/gmi-wolf-im-schafspelz-im-pflanzengenom-listige-vermehrungsstrategie-von-parasitaerer-dns/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/pfizer-im-kampf-gegen-krebs/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/vetmeduni-vienna-a-healthy-balance-a-model-for-studying-cancer-and-immune-diseases/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/ccc-plays-a-major-role-in-the-first-european-bill-of-rights-for-cancer-patients/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/arab-health-2014/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-vienna-recreational-skiing-an-ideal-family-sport-but-dont-underestimate-the-dangers/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-vienna-lung-cancer-self-protection-of-tumour-cells-can-be-blocked/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/mfpl-sometimes-the-average-just-isnt-good-enough/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/stadt-wien-brauner-innovative-betriebe-foerdern-neue-jobchancen-schaffen/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/imp-defect-in-ikaros-gene-mimics-human-b-cell-leukemia/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/otto-bock-outstanding-design-from-austria-for-the-worlds-best-knee-from-ottobock/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/meduni-vienna-new-possibilities-for-better-thrombosis-prognosis/ 2018-05-08T15:39:28+02:00 0.5 https://www.lisavienna.at/news/detail/haplogen-horizon-discovery-signs-distribution-agreement-with-haplogen/ 2018-05-08T15:32:55+02:00 0.5 https://www.lisavienna.at/news/detail/bmwfj-mitterlehner-finanzierungs-milliarde-2014-unterstuetzt-kmu-und-gruender/ 2018-05-08T15:39:28+02:00 0.5